National Institute for Occupational Safety and Health, Safety and Occupational Health Study Section, 55478 [06-8050]

Download as PDF 55478 Federal Register / Vol. 71, No. 184 / Friday, September 22, 2006 / Notices announces the following committee meeting. decision to designate a class of employees at the Ames laboratory, in Ames, Iowa, as an addition to the Special Exposure Cohort (SEC) under the Energy Employees Occupational Illness Compensation Program Act of 2000. On August 8, 2006, as provided for under 42 U.S.C. 7384q(b), the Secretary of HHS designated the following class of employees as an addition to the SEC: Department of Energy (DOE) employees or DOE contractor of subcontractor employees who worked at the Ames Laboratory in one or more of the following facilities/locations: Chemistry Annex 1 (also known as ‘‘the old women’s gymnasium’’ and ‘‘Little Ankeny’’), Chemistry Annex 2, chemistry Building (also known as ‘‘Gilman Hall’’), Research Building, or the Metallurgical Building (also known as ‘‘Harley Wilhelm Hall’’) from January 1, 1942 through December 31, 1954 for a number of work days aggregating at least 250 work days, or in combination with work days within the parameters (excluding aggregate work day requirements) established for one or more classes of employees in the SEC, and who were monitored or should have been monitored. This designation became effective on September 7, 2006, as provided for under 42 U.S.C. 7384l(14)(C). Hence, beginning on September 7, 2006, members of this class of employees, defined as reported in this notice, became members of the Special Exposure Cohort. FOR FURTHER INFORMATION CONTACT: Larry Elliott, Director, Office of Compensation Analysis and Support, National Institute for Occupational Safety and Health, 4676 Columbia Parkway, MS C–46, Cincinnati, OH 45226, telephone 513–533–6800 (this is not a toll-free number). Information requests can also be submitted by e-mail to OCAS@CDC.GOV. Dated: September 18, 2006. John Howard, Director, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention. [FR Doc. 06–7975 Filed 9–21–06; 8:45 am] BILLING CODE 4163–19–M DEPARTMENT OF HEALTH AND HUMAN SERVICES sroberts on PROD1PC70 with NOTICES Centers for Disease Control and Prevention National Institute for Occupational Safety and Health, Safety and Occupational Health Study Section In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) VerDate Aug<31>2005 20:37 Sep 21, 2006 Jkt 208001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Name: Safety and Occupational Health Study Section (SOHSS), National Institute for Occupational Safety and Health (NIOSH). Times and Dates: 8 a.m.–8:30 a.m., October 10, 2006 (Open). 8:30 a.m.–5 p.m., October 10, 2006 (Closed). 8:30 a.m.–5 p.m., October 11, 2006 (Closed). Place: Embassy Suites Hotel, 1900 Diagonal Road, Alexandria, Virginia 22314, telephone 703.684.5900, fax 703.684.1403. Purpose: The Safety and Occupational Health Study Section will review, discuss, and evaluate grant application(s) received in response to the Institute’s standard grants review and funding cycles pertaining to research issues in occupational safety and health, and allied areas. It is the intent of NIOSH to support broadbased research endeavors in keeping with the Institute’s program goals. This will lead to improved understanding and appreciation for the magnitude of the aggregate health burden associated with occupational injuries and illnesses, as well as to support more focused research projects, which will lead to improvements in the delivery of occupational safety and health services, and the prevention of work-related injury and illness. It is anticipated that research funded will promote these program goals. Matters to be Discussed: The meeting will convene in open session from 8–8:30 a.m. on October 10, 2006, to address matters related to the conduct of Study Section business. The remainder of the meeting will proceed in closed session. The purpose of the closed session is for the study section to consider safety and occupational health-related grant applications. These portions of the meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Section 10(d) Pub. L. 92–463. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Price Connor, PhD, NIOSH Health Scientist, 1600 Clifton Road, NE., Mailstop E–20, Atlanta, Georgia 30333, telephone 404.498.2511, fax 404.498.2569. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both CDC and the Agency for Toxic Substances and Disease Registry. Centers for Medicare & Medicaid Services Dated: September 18, 2006. Alvin Hall, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 06–8050 Filed 9–21–06; 8:45 am] BILLING CODE 4163–18–P PO 00000 Frm 00063 Fmt 4703 Sfmt 4703 [Document Identifier: CMS–10182, CMS– 10194, CMS–R–136 and CMS–10185] Agency Information Collection Activities: Submission for OMB Review; Comment Request Centers for Medicare & Medicaid Services, HHS. In compliance with the requirement of section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, the Centers for Medicare & Medicaid Services (CMS), Department of Health and Human Services, is publishing the following summary of proposed collections for public comment. Interested persons are invited to send comments regarding this burden estimate or any other aspect of this collection of information, including any of the following subjects: (1) The necessity and utility of the proposed information collection for the proper performance of the Agency’s function; (2) the accuracy of the estimated burden; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. 1. Type of Information Collection Request: Revision of a currently approved collection; Title of Information Collection: Model Creditable Coverage Disclosure Notices; Use: Section 1860D—1 of the MMA requires entities that offer prescription drug benefits under any of the types of coverage described in 42 CFR 423.56(b) to provide a disclosure of creditable coverage status to all Medicare Part D eligible individuals covered under the entity’s plan. These disclosure notices must be provided to Part D eligible individuals, at a minimum, at the following times: (1) Prior to an individual’s initial enrollment period for Part D, (2) prior to the effective date of enrollment in the entity’s coverage, and upon any change in creditable status; (3) prior to the commencement of the Part D Annual Coordinated Election Period (ACEP) which begins on November 15 of each year, and (4) upon request by the individual. Disclosure of whether prescription drug coverage is creditable provides Medicare eligible individuals with important information relating to their Medicare Part D enrollment. Form Number: CMS–10182 (OMB#: 0938–0990); Frequency: AGENCY: E:\FR\FM\22SEN1.SGM 22SEN1

Agencies

[Federal Register Volume 71, Number 184 (Friday, September 22, 2006)]
[Notices]
[Page 55478]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-8050]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


National Institute for Occupational Safety and Health, Safety and 
Occupational Health Study Section

    In accordance with section 10(a)(2) of the Federal 
AdvisoryCommittee Act (Pub. L. 92-463), the Centers for DiseaseControl 
and Prevention (CDC) announces the following committee meeting.

    Name: Safety and Occupational Health Study Section (SOHSS), 
National Institute for Occupational Safety and Health(NIOSH).
    Times and Dates:

8 a.m.-8:30 a.m., October 10, 2006 (Open).
    8:30 a.m.-5 p.m., October 10, 2006 (Closed).
    8:30 a.m.-5 p.m., October 11, 2006 (Closed).

    Place: Embassy Suites Hotel, 1900 Diagonal Road, Alexandria, 
Virginia 22314, telephone 703.684.5900, fax 703.684.1403.
    Purpose: The Safety and Occupational Health Study Section will 
review, discuss, and evaluate grant application(s) received in 
response to the Institute's standard grants review and funding 
cycles pertaining to research issues in occupational safety and 
health, and allied areas.
    It is the intent of NIOSH to support broad-based research 
endeavors in keeping with the Institute's program goals. This will 
lead to improved understanding and appreciation for the magnitude of 
the aggregate health burden associated with occupational injuries 
and illnesses, as well as to support more focused research projects, 
which will lead to improvements in the delivery of occupational 
safety and health services, and the prevention of work-related 
injury and illness. It is anticipated that research funded will 
promote these program goals.
    Matters to be Discussed: The meeting will convene in open 
session from 8-8:30 a.m. on October 10, 2006, to address matters 
related to the conduct of Study Section business. The remainder of 
the meeting will proceed in closed session. The purpose of the 
closed session is for the study section to consider safety and 
occupational health-related grant applications. These portions of 
the meeting will be closed to the public in accordance with 
provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., 
and the Determination of the Director, Management Analysis and 
Services Office, CDC, pursuant to Section 10(d) Pub. L. 92-463.
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Price Connor, PhD, NIOSH 
Health Scientist, 1600 Clifton Road, NE., Mailstop E-20, Atlanta, 
Georgia 30333, telephone 404.498.2511, fax 404.498.2569.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: September 18, 2006.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 06-8050 Filed 9-21-06; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.